KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Common Equity (2016 - 2025)

Historic Common Equity for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $789.1 million.

  • Astrana Health's Common Equity rose 1119.7% to $789.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $789.1 million, marking a year-over-year increase of 1119.7%. This contributed to the annual value of $716.7 million for FY2024, which is 1622.88% up from last year.
  • As of Q3 2025, Astrana Health's Common Equity stood at $789.1 million, which was up 1119.7% from $771.5 million recorded in Q2 2025.
  • Astrana Health's 5-year Common Equity high stood at $789.1 million for Q3 2025, and its period low was $347.0 million during Q1 2021.
  • Moreover, its 5-year median value for Common Equity was $569.8 million (2023), whereas its average is $581.6 million.
  • As far as peak fluctuations go, Astrana Health's Common Equity soared by 9214.67% in 2021, and later surged by 1119.7% in 2025.
  • Astrana Health's Common Equity (Quarter) stood at $454.1 million in 2021, then increased by 19.86% to $544.3 million in 2022, then grew by 13.29% to $616.7 million in 2023, then rose by 16.23% to $716.7 million in 2024, then rose by 10.09% to $789.1 million in 2025.
  • Its last three reported values are $789.1 million in Q3 2025, $771.5 million for Q2 2025, and $750.4 million during Q1 2025.